US Patent Issued to Abbott Diabetes Care on Feb. 25 for "Methods, devices, and systems for physiological parameter analysis" (California Inventor)

ALEXANDRIA, Va., Feb. 26 -- United States Patent no. 12,232,867, issued on Feb. 25, was assigned to Abbott Diabetes Care Inc. (Alameda, Calif.).

"Methods, devices, and systems for physiological parameter analysis" was invented by Yongjin Xu (San Ramon, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of calculating at least one physiological parameter using a reticulocyte production index (RPI) value can include: measuring a plurality of first glucose levels over a first time period; measuring a first glycated hemoglobin (HbA1c) level corresponding to an end of the first time period; measuring the RPI value; calculating a red blood cell elimination constant (kage) based on the RPI value; and ca...